https://www.zacks.com/stock/news/2334051/will-trinity-biotech-stock-gain-from-its-latest-patent-process?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2334051
Sep 10, 2024 - TRIB announces updates on its European patented process. The company aims to use this process to improve the functionality of its glucose biosensor in its next-gen CGM technology.
zc:-1475315024251557468
0
https://www.zacks.com/stock/news/2333652/5-top-red-hot-stocks-to-buy-now?cid=CS-ZC-FT-market_edge-2333652
Sep 09, 2024 - he hottest stocks might not be those you think. Look past AI and technology stocks.
zc:-3735829483110173717
0
https://www.zacks.com/stock/news/2333633/here-s-why-universal-health-shares-are-attracting-investors-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2333633
Sep 09, 2024 - UHS remains well-poised for growth on improved patient days at its behavioral healthcare facilities, acquisitions and solid cash flows.
zc:-1618517138327375468
0
https://www.zacks.com/stock/news/2333619/pbh-stock-might-get-a-boost-from-focused-brand-building-efforts?cid=CS-ZC-FT-analyst_blog|zer_report_update-2333619
Sep 09, 2024 - Prestige Consumer puts emphasis on brand building and product innovation in niche consumer healthcare categories to improve the lives of its consumers.
zc:-7257590940456791285
0
https://www.zacks.com/stock/news/2331577/new-partnerships-to-aid-myriad-genetics-stock-amid-macro-issues?cid=CS-ZC-FT-analyst_blog|zer_report_update-2331577
Sep 04, 2024 - MYGN focuses on effective capital deployment in key areas, including new tech-enabled tools and capabilities, innovation and commercial capabilities.
zc:7775643272111036410
0
https://www.zacks.com/stock/news/2330816/reasons-to-hold-tandem-diabetes-stock-in-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2330816
Sep 03, 2024 - Innovations and a robust diabetes market outlook raise investors' optimism for TNDM.
zc:3111815378856193945
0
https://www.zacks.com/stock/news/2330140/favorable-clinical-results-for-hyla-sensor-might-boost-inspira-stock?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2330140
Sep 02, 2024 - IINN plans to report clinical results for its new HYLA blood sensor in open-heart surgery patients in the fourth quarter of 2024.
zc:-7376283067992271297
0
https://www.zacks.com/stock/news/2329694/market-share-gains-aid-zimmer-biomet-stock-amid-cost-pressure?cid=CS-ZC-FT-analyst_blog|zer_report_update-2329694
Aug 30, 2024 - In terms of Persona cementless Knee, ZBH is currently witnessing strong uptake of the cementless platform Persona OsseoTi.
zc:6543676575677152746
0
https://www.zacks.com/stock/news/2329688/new-launches-support-tandem-diabetes-stock-despite-macro-concerns?cid=CS-ZC-FT-analyst_blog|zer_report_update-2329688
Aug 30, 2024 - The latest addition to TNDM's pump platform portfolio, Tandem Mobi, is leading the way in creating a whole new category of devices for insulin therapy.
zc:-6983494182036629539
0
https://www.fool.com/investing/2024/08/30/2-top-healthcare-growth-stocks-to-buy-right-now/?source=iedfolrf0000001
Aug 30, 2024 - These businesses are profitable and growing steadily.
0
fool:-7317305818527534898
0